0001209191-23-025285.txt : 20230421 0001209191-23-025285.hdr.sgml : 20230421 20230421204449 ACCESSION NUMBER: 0001209191-23-025285 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230419 FILED AS OF DATE: 20230421 DATE AS OF CHANGE: 20230421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATTINGLY MARTIN A CENTRAL INDEX KEY: 0001265782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36818 FILM NUMBER: 23837736 MAIL ADDRESS: STREET 1: C/O TRIMERIS, INC. STREET 2: 2530 MERIDIAN PARKWAY, 2ND FLOOR CITY: DURHAM STATE: NC ZIP: 27713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tracon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001394319 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 342037594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4350 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 800 CITY: San Diego STATE: CA ZIP: 92122 BUSINESS PHONE: 858-550-0780 MAIL ADDRESS: STREET 1: 4350 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 800 CITY: San Diego STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Tracon Pharmaceuticals Inc DATE OF NAME CHANGE: 20070324 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-19 0 0001394319 Tracon Pharmaceuticals, Inc. TCON 0001265782 MATTINGLY MARTIN A C/O TRACON PHARMACEUTICALS, INC. 4350 LA JOLLA VILLAGE DRIVE, SUITE 800 SAN DIEGO CA 92122 1 0 0 0 0 Director Stock Option (Right to Buy) 1.82 2023-04-19 4 A 0 18000 0.00 A 2033-04-18 Common Stock 18000 18000 D The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan). /s/ Scott B. Brown, Attorney-in-Fact 2023-04-21